Indra Bhattacharya has more than eight years of experience in high-value IP disputes across a range of industry sectors, including pharmaceuticals, biotechnology, medical devices, and consumer technology and electronics. He is also experienced in commercial IP matters and in technology-rich corporate transactions.
Indra has acted for some of world's leading pharmaceutical and medical device companies, including Abbott, Actavis, Celgene, and Merck in multijurisdictional high-profile patent disputes in the United Kingdom, Asia, and Australia. He is part of the Firm's award winning life sciences practice and regularly acts in transactions in the pharmaceutical field and advises on freedom to operate issues. He also has acted on trademark, design rights, and breach of confidence cases in the technology and retail sectors. He is experienced litigating before English and Australian courts.
In addition, he has significant regulatory experience having spent time in-house in pharmaceutical and research institutions. This includes pharmaceutical and medical devices regulation along with food safety and hygiene issues. He also regularly assists clients on investigations with regulators, including the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA).
Indra holds a first class degree in law and is technically qualified with a degree in genetics and biochemistry. He has previously lectured on intellectual property law.
- September 30, 2015
Approach to '2nd Medical Use' Claims Varies Across EU, Law 360
- University of Melbourne (Graduate Diploma in Intellectual Property 2009); University of Adelaide (LL.B. with first class honours 2004; B.S. in Genetics & Biochemistry 2004)
- Solicitor of the Senior Courts of England and Wales and legal practitioner of the Supreme Courts of New South Wales, Western Australia, and Victoria and the Australian Federal Courts